Pfizer leads the way for pharma companies at Biolake
By Wang Huazhong and Zhou Lihua | China Daily USA | Updated: 2016-06-29
In 2010 Pfizer was the first Fortune 500 company to settle in the newly established National Bio-industry Base in Wuhan, also known as Biolake.
Following in Pfizer's steps, eight of 13 pharmaceutical companies from the Fortune 500 list now have a presence at Biolake as the bio-industry base leads a State program to rely on innovation to upgrade the economic structure of Wuhan, which was once dominated by heavy industries and a renowned steel producer in central China.
“Every one of Pfizer's new drugs has indispensable contributions from the Wuhan team." According to Lan
"No other but our Wuhan teams manage the clinical trial registry information and clinical trial master files for all Pfizer's medicines. By 2015 Pfizer was moving its “medicine safety business” from India to the Wuhan Biolake facility. https://archive.md/puanr
According to a data leak, Pfizer has employed 69 known members of the Chinese Communist Party; around 500 people work (2016) at their Wuhan site. See: “Huge Data Leak of 2 Million CCP Members Reveals ‘Golden Age’ of Chinese Espionage” By Daniel Y. Teng, December 14, 2020 https://archive.vn/5O49L
As of December 2020 Pfizer’s SEC filing still listed the following subsidiaries in Communist China: Pfizer (China) Research and Development Co. Ltd, Pfizer (Wuhan) Research and Development Co. Ltd., and Pfizer Biologics (Hangzhou) Co. Ltd., as well as Pfizer International Trading (Shanghai) Limited, Pfizer Investment Co. Ltd., Pfizer Pharmaceutical (Wuxi) Co., Ltd., Pfizer Pharmaceuticals Science and Technology Co., Ltd., Pfizer Finance Share Service (Dalian) Co., Ltd. https://archive.md/SMPQa
Funny thing that the Wuhan R&D isn’t listed as one of their R&D locations on the Pfizer web site. Even prior to the Covid-19 outbreak it wasn’t listed!!: https://web.archive.org/web/20190321054103/https://www.pfizer.com/science/research-development/centers
If you do a search for Wuhan on their web site, you don’t find it, as of this writing. If you type China in the search you find some relevant things.
On a separate Pfizer (China) site (last updated in 2011) one can find regarding Pfizer’s China Research and Development Center (Shanghai and Wuhan): “CRDC supports Pfizer’s global biological and chemical pharmaceutical R&D programs across our clinical development pipeline, and serves as an important hub of Pfizer global and Asia-Pacific R&D activities. As such, CRDC is an integral part of Pfizer’s global R&D site network, providing support across many R&D disciplines, including clinical drug development, medical, regulatory and safety.” See this and more here: https://archive.md/IQBZy
Pfizer founded an R&D facility in Wuhan (October 8, 2010) at China’s National Bio-industry Base in Wuhan (Biolake).
Lan Zhanghua, site head of Pfizer (Wuhan) Research & Development Co Ltd. stated: “Every one of Pfizer’s new drugs has indispensable contributions from the Wuhan team.“
Whereas Pfizer’s Wuhan team started “performing only one function, (now they do) 12 functions in the R&D system. Two functions run exclusively at Wuhan and nowhere else in the world: ‘No other but our Wuhan teams manage the clinical trial registry information and clinical trial master files for all Pfizer’s medicines. These are of utmost importance – making any mistake or losing documents could mean the medicine would never go to market,’ Lan said.”
At least eight of thirteen Fortune 500 pharmaceutical companies were located there, as of 2016. “Pfizer leads the way for pharma companies at Biolake” By Wang Huazhong and Zhou Lihua , China Daily USA, 2016-06-29 https://archive.is/puanr
“Medicine safety business of Pfizer transferred to Wuhan” Source: hubei. gov. cn 04/30/2015 https://archive.md/SKyM5
US Pfizer, Germany’s Bayer, Fresenius Kabi, Thermo Fisher, Honeywell and DuPont Pioneer were all located at Biolake, Wuhan, as of 2013: “8 world top 500 biopharmaceutical companies located in Wuhan” Source: hubei. gov. cn 11/18/2013 10:11:09 See: https://archive.md/w9QJd
In 2009 “Pfizer noted that its Wuhan operation will liaise with local research institutes and universities “utilising the rich resources of local talent and existing industry capabilities to develop research collaborations”. See: “Pfizer to build R&D facility in Wuhan, China” 25th November 2009 by Kevin Grogan Pharma Times: https://archive.md/0M2Gx
located in Wuhan East Lake High-tech Development Zone”: “Pfizer building in the Biolake” photo https://archive.md/VYUZF
BioProcess International Spotlight by BPI Staff Wednesday, December 16, 2015 featured JHL Biotech’s Wuhan facility. Excerpts: “The world’s largest bio-manufacturing plant based on single-use technology has been constructed for JHL Biotech at the Biolake science park in Wuhan, China….The Biolake site is designed to accommodate increasing local demand for biosimilars and innovative biopharmaceuticals. https://archive.md/IzAUE
December 16, 2015 BPI article was “US Biodefense Study Emboldens Biotech”: “In late October the Blue Ribbon Study Panel on Biodefense in the United States released its final report (www.biodefensestudy.org) recommending new approaches to developing medical countermeasures more quickly for emerging infectious disease threats…. The report calls out the crucial role of drug and vaccine medical countermeasures and the need for significant government funding…” https://archive.md/IzAUE
…….
In 2009 “Pfizer noted that its Wuhan operation will liaise with local research institutes and universities “utilising the rich resources of local talent and existing industry capabilities to develop research collaborations”.
https://miningawareness.wordpress.com/2021/07/22/pfizer-has-large-rd-facility-in-wuhan-china-pfizer-employed-members-of-the-chinese-communist-party-according-to-a-data-leak-pfizer-3-month-revenue-from-the-covid-vaccine-was-3-5-billion/
…………………….
No comments:
Post a Comment